A retrovirus known as human T-cell lymphotropic virus type 1 (HTLV-1) is known to cause a number of diseases, including inflammatory diseases of the eye. Recently, researchers in Japan have ...
The FINANCIAL — Bayer HealthCare and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on November 22 announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think they know why. Photo by Adobe Stock/HealthDay News Current treatments ...
In a recent study, Moran Eye Center's Dr. Mary Elizabeth Hartnett looks for a way to fix or maintain the retinal pigment epithelial (RPE) barrier. And she found it in the protein RAP1A. Her research, ...
Hosted on MSN
Macular Degeneration Breakthroughs
New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port" ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Of three ...
Tear fluid is emerging as an attractive source of diagnostic information because it can be collected easily and noninvasively ...
A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The drug also showed potential efficacy in patients who failed to optimally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results